Saturday, January 31, 2026

Military Officer Linked to Pyongyang Drone Operation Undergoes Detention Hearing

Drone Operations Commander Kim Yong Dae faces detention for alleged treason and document forgery linked to a North Korea drone operation.

Samsung Heavy Industries Signs MOU With U.S. Shipyard Vigor Marine

Samsung Heavy Industries partners with Vigor Marine Group to enhance U.S. Navy MRO services and explore commercial vessel construction.

LG’s New OLED Screen Hits 1,500 Nits and 540Hz — Here’s Why That Matters

LG Display's new 27-inch OLED monitor features 1,500 nits brightness, 540 Hz refresh rate, and 0.03 ms response time for unmatched performance.

Tag: Samsung Bioepis

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us